OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Antitumoral Activity of the MEK Inhibitor Trametinib (TMT212) Alone and in Combination with the CDK4/6 Inhibitor Ribociclib (LEE011) in Neuroendocrine Tumor Cells In Vitro
Xi‐Feng Jin, Gerald Spöttl, Julian Maurer, et al.
Cancers (2021) Vol. 13, Iss. 6, pp. 1485-1485
Open Access | Times Cited: 5
Xi‐Feng Jin, Gerald Spöttl, Julian Maurer, et al.
Cancers (2021) Vol. 13, Iss. 6, pp. 1485-1485
Open Access | Times Cited: 5
Showing 5 citing articles:
Genomic characterization reveals distinct mutation landscapes and therapeutic implications in neuroendocrine carcinomas of the gastrointestinal tract
Huanwen Wu, Zicheng Yu, Yueping Liu, et al.
Cancer Communications (2022) Vol. 42, Iss. 12, pp. 1367-1386
Open Access | Times Cited: 21
Huanwen Wu, Zicheng Yu, Yueping Liu, et al.
Cancer Communications (2022) Vol. 42, Iss. 12, pp. 1367-1386
Open Access | Times Cited: 21
Targeting Key Players of Neuroendocrine Differentiation in Prostate Cancer
Irene Zamora, Michael R. Freeman, Ignacio Encı́o, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 18, pp. 13673-13673
Open Access | Times Cited: 6
Irene Zamora, Michael R. Freeman, Ignacio Encı́o, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 18, pp. 13673-13673
Open Access | Times Cited: 6
MEK inhibition causes BIM stabilization and increased sensitivity to BCL-2 family member inhibitors in RAS-MAPK-mutated neuroblastoma
Thomas F. Eleveld, Lindy Vernooij, Linda Schild, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 4
Thomas F. Eleveld, Lindy Vernooij, Linda Schild, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 4
Direct Targeting of the Raf-MEK-ERK Signaling Cascade Inhibits Neuroblastoma Growth
Rameswari Chilamakuri, Saurabh Agarwal
Current Oncology (2022) Vol. 29, Iss. 9, pp. 6508-6522
Open Access | Times Cited: 5
Rameswari Chilamakuri, Saurabh Agarwal
Current Oncology (2022) Vol. 29, Iss. 9, pp. 6508-6522
Open Access | Times Cited: 5
Cyclin-dependent Kinases 4/6 Inhibitors in Neuroendocrine Neoplasms: from Bench to Bedside
Maria João Sousa, Lorenzo Gervaso, Mónica Isabel Meneses Medina, et al.
Current Oncology Reports (2022) Vol. 24, Iss. 6, pp. 715-722
Closed Access | Times Cited: 4
Maria João Sousa, Lorenzo Gervaso, Mónica Isabel Meneses Medina, et al.
Current Oncology Reports (2022) Vol. 24, Iss. 6, pp. 715-722
Closed Access | Times Cited: 4
